Commodore Capital as of March 31, 2021
Portfolio Holdings for Commodore Capital
Commodore Capital holds 31 positions in its portfolio as reported in the March 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Aclaris Therapeutics (ACRS) | 10.2 | $26M | 1.0M | 25.20 | |
| C4 Therapeutics Com Stk (CCCC) | 7.0 | $18M | 481k | 36.99 | |
| Kura Oncology (KURA) | 5.8 | $15M | 522k | 28.27 | |
| Satsuma Pharmaceuticals Ord | 5.7 | $14M | 2.4M | 5.91 | |
| Five Prime Therapeutics | 5.4 | $14M | 361k | 37.67 | |
| Cymabay Therapeutics | 5.3 | $14M | 3.0M | 4.54 | |
| Cogent Biosciences (COGT) | 4.4 | $11M | 1.3M | 8.78 | |
| Iveric Bio | 4.2 | $11M | 1.7M | 6.18 | |
| Protagonist Therapeutics (PTGX) | 3.6 | $9.1M | 350k | 25.90 | |
| Kronos Bio | 3.4 | $8.7M | 299k | 29.27 | |
| Constellation Pharmceticls I | 3.4 | $8.6M | 368k | 23.39 | |
| Trillium Therapeutics Com New | 3.4 | $8.5M | 796k | 10.74 | |
| Vistagen Therapeutics Com New | 3.1 | $7.9M | 3.7M | 2.13 | |
| Genocea Biosciences Com New (GNCAQ) | 3.1 | $7.8M | 2.9M | 2.71 | |
| Celldex Therapeutics Com New (CLDX) | 3.0 | $7.6M | 370k | 20.60 | |
| Mersana Therapeutics | 2.7 | $6.9M | 429k | 16.18 | |
| Mereo Biopharma Group Ads (MREO) | 2.7 | $6.9M | 2.0M | 3.37 | |
| Dyne Therapeutics (DYN) | 2.6 | $6.7M | 430k | 15.53 | |
| Miragen Therapeutics (VRDN) | 2.4 | $6.1M | 366k | 16.71 | |
| Relmada Therapeutics (RLMD) | 2.2 | $5.7M | 162k | 35.21 | |
| Kalvista Pharmaceuticals (KALV) | 2.2 | $5.5M | 215k | 25.69 | |
| Xenon Pharmaceuticals (XENE) | 2.1 | $5.4M | 301k | 17.90 | |
| Syndax Pharmaceuticals (SNDX) | 2.1 | $5.3M | 237k | 22.36 | |
| Essa Pharma Com New (EPIX) | 2.0 | $5.1M | 177k | 29.05 | |
| Silverback Therapeutics (SPRY) | 1.7 | $4.2M | 97k | 43.63 | |
| Pmv Pharmaceuticals (PMVP) | 1.6 | $4.1M | 125k | 32.89 | |
| Inventiva Sa Ads (IVA) | 1.5 | $3.9M | 263k | 14.70 | |
| Seres Therapeutics | 1.1 | $2.9M | 141k | 20.59 | |
| Bcls Acquisition Corp Com Cl A | 1.0 | $2.6M | 250k | 10.57 | |
| Macrogenics (MGNX) | 0.6 | $1.5M | 47k | 31.85 | |
| Lifesci Acquisition Ii Corp | 0.4 | $1.0M | 100k | 10.14 |
